Eugenix Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.75 M
- Revenue Growth -13.54%
- Profit Growth 86.26%
- Ebitda 97.29%
- Net Worth 2.88%
- Total Assets 3.75%
About Eugenix Biotech
Eugenix Biotech Private Limited (EBPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 October 2014 and has a history of Ten years and four months. Its registered office is in Delhi, India.
The Corporate was formerly known as Dermis Health Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.75 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Arika Bansal and Pradeep Sethi serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85100DL2014PTC272572
-
Company No.
272572
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Oct 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Eugenix Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arika Bansal
|
Director | 01-May-2016 | Current |
|
Pradeep Sethi
|
Director | 17-Oct-2014 | Current |
Financial Performance of Eugenix Biotech.
Eugenix Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.54% decrease. The company also saw a substantial improvement in profitability, with a 86.26% increase in profit. The company's net worth moved up by a moderate rise of 2.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eugenix Biotech?
Unlock access to Eugenix Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Eugenix Hair Sciences Private LimitedArika Bansal and Pradeep Sethi are mutual person
Charges (Loans)
₹0
₹2.75 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.27 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2015 | Hdfc Bank Limited | ₹2.75 M | Satisfied |
How Many Employees Work at Eugenix Biotech?
Unlock and access historical data on people associated with Eugenix Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eugenix Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eugenix Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
